AllianceBernstein’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,040
| Closed | -$119K | – | 3286 |
|
|
2025
Q1 | $119K | Hold |
11,040
| – | – | ﹤0.01% | 3040 |
|
|
2024
Q4 | $141K | Hold |
11,040
| – | – | ﹤0.01% | 3086 |
|
|
2024
Q3 | $305K | Hold |
11,040
| – | – | ﹤0.01% | 2910 |
|
|
2024
Q2 | $320K | Buy |
11,040
+2,298
| +26% | +$66.6K | ﹤0.01% | 2889 |
|
|
2024
Q1 | $390K | Sell |
8,742
-471
| -5% | -$21K | ﹤0.01% | 2693 |
|
|
2023
Q4 | $357K | Buy |
9,213
+480
| +5% | +$18.6K | ﹤0.01% | 2769 |
|
|
2023
Q3 | $257K | Buy |
8,733
+410
| +5% | +$12.1K | ﹤0.01% | 2866 |
|
|
2023
Q2 | $529K | Hold |
8,323
| – | – | ﹤0.01% | 2611 |
|
|
2023
Q1 | $393K | Buy |
8,323
+850
| +11% | +$40.1K | ﹤0.01% | 2671 |
|
|
2022
Q4 | $519K | Hold |
7,473
| – | – | ﹤0.01% | 2611 |
|
|
2022
Q3 | $1.1M | Hold |
7,473
| – | – | ﹤0.01% | 2227 |
|
|
2022
Q2 | $974K | Hold |
7,473
| – | – | ﹤0.01% | 2356 |
|
|
2022
Q1 | $755K | Buy |
+7,473
| New | +$755K | ﹤0.01% | 2508 |
|
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$1.62M | – | 3307 |
|
|
2021
Q2 | $1.62M | Buy |
+5,000
| New | +$1.62M | ﹤0.01% | 2291 |
|